Brokerages Set WELL Health Technologies Corp. (TSE:WELL) Target Price at C$7.39

Shares of WELL Health Technologies Corp. (TSE:WELL) have been assigned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is C$7.39.

WELL has been the topic of a number of recent analyst reports. CIBC lowered shares of WELL Health Technologies from an “outperform” rating to a “neutral” rating and cut their price objective for the stock from C$5.50 to C$4.75 in a report on Monday, January 22nd. Pi Financial raised their price objective on shares of WELL Health Technologies from C$8.25 to C$8.50 in a report on Wednesday, January 31st. Finally, Royal Bank of Canada set a C$5.50 target price on shares of WELL Health Technologies and gave the company an “outperform” rating in a research note on Tuesday, February 6th.

WELL Health Technologies Stock Down 0.3 %

Shares of WELL Health Technologies stock opened at C$3.50 on Friday. The company has a fifty day moving average price of C$3.83 and a 200 day moving average price of C$3.88. The company has a current ratio of 1.15, a quick ratio of 1.02 and a debt-to-equity ratio of 50.38. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$5.94. The stock has a market cap of C$859.71 million, a price-to-earnings ratio of -185.00, a price-to-earnings-growth ratio of -1.93 and a beta of 1.27.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.